Skip to content

Effects of Protein Type and Mineral Form on Amino Acid Availability

Effects of Protein Type and Mineral Form on Postprandial Amino Acid Availability in Healthy Young Adults: a Randomized Cross-over Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07677098
Acronym
ProMin
Enrollment
16
Registered
2026-06-30
Start date
2026-09-15
Completion date
2027-07-15
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Metabolism

Keywords

Amino acid, Satiety hormone, Minerals, Protein kinetics

Brief summary

To compare postprandial plasma amino acid availability, expressed as incremental area under the curve (iAUC), over a 6 hour period following ingestion of 25 g of different protein isolates in healthy, young adults. The primary objective is divided into the following 2 sub-studies, each with 3 comparisons: * Sub-study 1: whey protein, calcium caseinate, sodium caseinate. * Sub-study 2: calcium caseinate, magnesium caseinate, potassium caseinate.

Detailed description

All living tissues are in a constant state of protein turnover, with synthesis and breakdown processes ensuring structural integrity, metabolic flexibility and the capacity for repair. Amino acids are the building blocks of proteins and must be supplied through the diet to maintain a positive protein balance. Ingestion of high-quality protein sources (e.g. meat, dairy) leads to a postprandial increase in circulating amino acids, and as such can facilitate tissue protein synthesis. The magnitude and the kinetics of the amino acid response largely depend on the amino acid composition combined with protein digestion and amino acid absorption rate. Beyond their structural role, amino acids also function as signalling molecules involved in gastrointestinal hormone secretion and appetite control. One such key hormone is glucagon-like peptide 1 (GLP-1), a gut-derived hormone that plays an essential role in metabolic regulation such as insulin secretion and appetite suppression. Given its role in metabolic health, particularly in the context of obesity and type 2 diabetes, increasing GLP-1 availability has become a target for support in metabolic care. However, many pharmacological approaches to elevate GLP-1 are costly and carry risks of harmful side-effects. Nutritional strategies that modulate GLP-1 secretion and availability therefore offer an attractive alternative. Emerging evidence suggests that not only protein ingestion itself, but also the matrix in which the protein is delivered can modulate GLP-1 secretion. For example, co- ingestion of specific minerals, especially calcium, has been shown to enhance GLP-1 secretion beyond the effects of protein ingestion alone. These data indicate that mineral-protein interactions may play a meaningful role in appetite regulation and metabolic signalling, warranting further investigation. Bovine milk contains two primary high-quality protein fractions: whey (\ 20%) and casein (\ 80 %). Whey protein is rapidly digested, resulting in fast but transient increases in circulating amino acids, whereas casein protein is digested more slowly, leading to more prolonged but sustained amino acid availability (13-15). To optimize the functional properties of casein, various processing techniques can be applied, including the formation of caseinate salts through binding casein with different minerals such as calcium, sodium, magnesium, and potassium. These caseinate forms differ in mineral composition, which may influence not only digestion and absorption kinetics, but also GLP-1 secretion capacity. Although the differences in digestion kinetics between whey and casein are well-established, a direct comparison of postprandial amino acid and GLP-1 responses following ingestion of whey versus various mineral-bound caseinates has not yet been performed.

Interventions

DIETARY_SUPPLEMENTProtein beverage

25 g protein isolate, dissolved in 500 mL water

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER
Friesland Campina
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

The protein drinks will be prepared by a member of the study team, not involved in the data collection. Subjects receive protein beverages in a non-transparent shaker.

Intervention model description

Within-subject, randomized, double-blind, cross-over design

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

To be eligible to participate in this study, a participant must meet all of the following criteria: * Male or female sex * Aged between 18 - 35 years inclusive * BMI between 18 - 30 kg/m2 * Healthy, recreationally active (exercise at least once per two weeks and a maximum of four days per week) * No physical limitations (i.e., able to perform all activities associated with daily living independently) A potential participant who meets any of the following criteria will be excluded from participation in this study: * Intolerant to milk protein and/or dairy-based products * Smoking regularly * Diagnosed with gastro-intestinal disorders * Diagnosed with metabolic disorders (e.g. diabetes) * Diagnosed with musculoskeletal disorders * Blood donation in the past 2 months * Females: pregnancy * Use of any medication known to affect protein metabolism (e.g. corticosteroids, non-steroidal anti-inflammatories or prescribed acne medications) * Chronic use of gastric acid suppressing drugs (e.g. proton pump inhibitors, H2-antagonists)

Design outcomes

Primary

MeasureTime frameDescription
Six-hour postprandial plasma total amino acid availability following ingestion of 25 grams of different protein isolates in healthy, young adultsSix hoursPlasma total amino acid availability is expressed as the incremental area under the curve (iAUC) and compared between whey protein, calcium caseinate and sodium caseinate (sub-study 1) and between calcium caseinate, magnesium caseinate and potassium caseinate (sub-study 2).

Secondary

MeasureTime frameDescription
Plasma essential amino acid concentrationsEssential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).The summed measurement of histidine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine concentrations
Non-essential amino acid concentrationsNonssential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).The summed measurement of alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, serine, tyrosine and valine concentrations
Plasma amino acid kineticsDuring the six-hour postprandial periodCompare peak plasma amino acid concentrations and the time to reach these peak concentrations of all individually measured amino acids
Circulating mineral concentrationsDuring the six-hour postprandial periodCalcium, magnesium, sodium, potassium and parathyroid hormone concentrations
Glucagon-like peptide-1 concentrationsDuring the six-hour postprandial periodPostprandial glucacon-like peptide-1 (GLP-1) concentrations

Countries

Netherlands

Contacts

CONTACTNoortje Boot, MSc
noortje.boot@maastrichtuniversity.nl088-3887246
CONTACTLuc van Loon, Prof., PhD
l.vanloon@maastrichtuniversity.nl043-3881397

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026